Transcription of Veritor™ System - BD
{{id}} {{{paragraph}}}
256082. 500048916(02). 2020-08. English Veritor System For Rapid detection of SARS-CoV-2. Kit configured for testing nasal swab samples freshly collected, processed and dispensed directly onto assay test device. In the USA: For use under an Emergency Use Authorization only. 30. Determinations 1. Veritor System For Rapid detection of SARS-CoV-2. For In Vitro Diagnostic Use For use with the BD Veritor Plus Analyzer running firmware version or later In the USA: For use under an Emergency Use Authorization only Please read these instructions completely before beginning testing of specimens. INTENDED USE. The BD Veritor System for Rapid detection of SARS-CoV-2 is a chromatographic digital immunoassay intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swabs from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic digital immunoassay intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swabs from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}